LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 0.17783 | 16.29 | 84.90 | 1126 | 766 | 1.4683 | 1.2572 | MN20160318_Q02 | I16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.17783 | 17.99 | 84.90 | 41 | 898 | 0.0456 | -0.1925 | MN20160318_Q02 | F22 |
| MCF 10A-H2B-mCherry | Neratinib | 0.17783 | 17.99 | 84.90 | 834 | 898 | 0.9277 | 0.9564 | MN20160318_Q02 | F22 |
| MCF 10A-H2B-mCherry | Neratinib | 0.17783 | 17.99 | 84.90 | 15 | 898 | 0.0167 | -0.3990 | MN20160318_Q02 | I16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.17783 | 17.99 | 84.90 | 1049 | 898 | 1.1669 | 1.0928 | MN20160318_Q02 | I16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.17783 | 19.69 | 84.90 | 52 | 1239 | 0.0420 | -0.1190 | MN20160318_Q02 | F22 |
| MCF 10A-H2B-mCherry | Neratinib | 0.17783 | 19.69 | 84.90 | 708 | 1239 | 0.5712 | 0.7304 | MN20160318_Q02 | F22 |
| MCF 10A-H2B-mCherry | Neratinib | 0.17783 | 19.69 | 84.90 | 19 | 1239 | 0.0153 | -0.3209 | MN20160318_Q02 | I16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.17783 | 19.69 | 84.90 | 1074 | 1239 | 0.8665 | 0.9273 | MN20160318_Q02 | I16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.17783 | 21.40 | 84.90 | 52 | 1454 | 0.0357 | -0.1127 | MN20160318_Q02 | F22 |
| MCF 10A-H2B-mCherry | Neratinib | 0.17783 | 21.40 | 84.90 | 770 | 1454 | 0.5293 | 0.7125 | MN20160318_Q02 | F22 |
| MCF 10A-H2B-mCherry | Neratinib | 0.17783 | 21.40 | 84.90 | 27 | 1454 | 0.0186 | -0.2438 | MN20160318_Q02 | I16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.17783 | 21.40 | 84.90 | 1044 | 1454 | 0.7177 | 0.8445 | MN20160318_Q02 | I16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.17783 | 23.10 | 84.90 | 58 | 1616 | 0.0359 | -0.0857 | MN20160318_Q02 | F22 |
| MCF 10A-H2B-mCherry | Neratinib | 0.17783 | 23.10 | 84.90 | 729 | 1616 | 0.4511 | 0.6584 | MN20160318_Q02 | F22 |
| MCF 10A-H2B-mCherry | Neratinib | 0.17783 | 23.10 | 84.90 | 28 | 1616 | 0.0173 | -0.2297 | MN20160318_Q02 | I16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.17783 | 23.10 | 84.90 | 1137 | 1616 | 0.7035 | 0.8412 | MN20160318_Q02 | I16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.17783 | 24.81 | 84.90 | 58 | 1769 | 0.0328 | -0.0833 | MN20160318_Q02 | F22 |
| MCF 10A-H2B-mCherry | Neratinib | 0.17783 | 24.81 | 84.90 | 756 | 1769 | 0.4272 | 0.6472 | MN20160318_Q02 | F22 |
| MCF 10A-H2B-mCherry | Neratinib | 0.17783 | 24.81 | 84.90 | 30 | 1769 | 0.0170 | -0.2113 | MN20160318_Q02 | I16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.17783 | 24.81 | 84.90 | 1042 | 1769 | 0.5889 | 0.7723 | MN20160318_Q02 | I16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.17783 | 26.51 | 84.90 | 62 | 1923 | 0.0322 | -0.0674 | MN20160318_Q02 | F22 |
| MCF 10A-H2B-mCherry | Neratinib | 0.17783 | 26.51 | 84.90 | 878 | 1923 | 0.4565 | 0.6803 | MN20160318_Q02 | F22 |
| MCF 10A-H2B-mCherry | Neratinib | 0.17783 | 26.51 | 84.90 | 41 | 1923 | 0.0213 | -0.1493 | MN20160318_Q02 | I16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.17783 | 26.51 | 84.90 | 1248 | 1923 | 0.6489 | 0.8168 | MN20160318_Q02 | I16 |